Trial Profile
Study of the clinical efficacy and number of days of tebipenem pivoxil administration for the treatment of pediatric bacterial pneumonia.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 May 2017
Price :
$35
*
At a glance
- Drugs Tebipenem pivoxil (Primary)
- Indications Bacterial infections; Pneumonia
- Focus Adverse reactions; Therapeutic Use
- 22 May 2017 Status changed from recruiting to completed.
- 07 Mar 2013 New trial record